- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03995953
Integrated Care Delivery of HIV Prevention and Treatment in AGYW in Zambia
Developing and Testing a Multi-level Package of Interventions for an Integrated Care Delivery Model of HIV Prevention and Treatment Targeting Adolescent Girls in Zambia
Study Overview
Status
Conditions
Detailed Description
The SHIELD intervention aims to improve HIV prevention and care for adolescent girls and young women (AGYW) in Zambia. It is based on social cognitive theory and includes a program for AGYW to increase knowledge, skills, and self-efficacy, as well as a program for family members to increase social support. The intervention also incorporates youth clubs facilitated by peer navigators and integrated wellness clinics (IWC) for sexual and reproductive health services. It will be tailored for five distinct groups based on age and HIV status, with modules covering HIV prevention and treatment, wellness, sexual health, stigma reduction, and healthcare access.
IWC clinics will be established in existing government health facilities, following a model similar to cervical cancer screening clinics. Standard operating procedures (SOPs) will be developed for HIV, HPV vaccination, and sexual and reproductive health services.
Time and motion methodology will monitor AGYW clinic visits to identify areas for improvement. To establish a sampling frame, the study team will identify six clinics in Lusaka, map neighborhoods within the selected clinic catchment areas, and recruit AGYW through household visits by peer navigators.
The HIV-/u cohort will include females aged 10-20 years with self-reported HIV-negative or unknown status. They must not be pregnant or planning pregnancy, be willing to sign a medical records release, plan to reside in the area for 18 months, and not be part of other formative research activities. The study will recruit 1,000 HIV-/u AGYW, with equal numbers in age ranges 10-12, 13-15, and 16-20.
The HIV+ cohort will consist of females aged 16-24 years, diagnosed with HIV within the past 3 years, and meeting the same additional criteria as the HIV-/u cohort. The study will enroll 800 HIV+ AGYW, with equal representation among 16-20 and 21-24 age groups.
AGYW will be encouraged to select caregivers who will participate in some of the education sessions. The role of the caregiver is to support AGYW. Primary and secondary outcomes will be reported for AGYW only.
Data collection will use electronic tablets with pre-loaded software and instruments in multiple languages. Voice-enabled components and self-administration options will be available for sensitive questions. Instruments will be pretested with AGYW and caregivers. The study team will abstract data from clinic records with support from the Zambian Ministry of Health, conducting pilot data abstraction and staff training to ensure high-quality data for the study.
Key aspects of the intervention include tailored education modules for AGYW and caregivers, youth clubs led by peer navigators, and integrated wellness clinics offering comprehensive sexual and reproductive health services.
The SHIELD study aims to improve HIV prevention and care for AGYW in Zambia by addressing knowledge, skills, self-efficacy, social support, and healthcare access through a comprehensive, theory-based intervention. By combining education, social support, and improved healthcare services, the researchers hope to make significant strides in reducing HIV transmission and improving health outcomes for adolescent girls and young women in Zambia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lusaka, Zambia
- Population Council
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
HIV negative or unknown cohort
- Female
- 10 to 20 years of age
- self-report HIV status as negative or unknown (no HIV testing within the past 6 months
- not pregnant, does not suspect pregnancy, and does not express a desire to become pregnant over the next 18 months
- is willing to sign a release for medical records (to obtain clinic data on service use)
- plans to reside in the current location for the next 18 months
- has not been part of the other planned formative research activities
HIV positive cohort
- Female
- 16 to 24 years of age
- diagnosed with HIV within the past 3 years or newly diagnosed at the time of the study
- not pregnant, does not suspect pregnancy, and does not express a desire to become pregnant over the next 18 months
- is willing to sign a release for medical records (to obtain clinic data on service use)
- plans to reside in the current location for the next 18 months
- has not been part of the other planned formative research activities
Exclusion Criteria:
- pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
2 control clinics, and their associated catchment areas, with no intervention at the clinic or community level
|
|
|
Experimental: SHIELD: Community-based behavioral intervention
2 clinics, and their associated catchment areas, where participants attend modules designed to educate and empower adolescent girls and young women (AGYWs) and their caregivers, along with attendance at community-based youth clubs to foster peer support.
|
The SHIELD intervention includes a three-session, six-module program for AGYW that increases knowledge, skills, and self-efficacy to engage along the HIV prevention and care continuum, and a two-session, four-module program for caregivers to increase social support.
In addition, the SHIELD intervention includes youth clubs to foster peer support.
|
|
Experimental: SHIELD: Community- based behavioral intervention & IWC Clinic
2 clinics, and their associated catchment areas, where participants and their caregivers receive the Support for HIV Integrated Education, Linkages to care, and Destigmatization (SHIELD) intervention along with the coupled benefits of having an integrated wellness care (IWC) clinic within health facilities where adolescent girls and young women (AGYWs) can receive sexual and reproductive health services, including HIV testing and treatment, family planning, sexually transmitted disease screening and treatment, and human papilloma virus (HPV) vaccination.
|
IWC clinics will be created within health facilities where AGYWs can receive sexual and reproductive health services, including HIV testing and treatment, family planning, sexually transmitted disease screening and treatment, and HPV vaccination in a youth-friendly environment.
The SHIELD intervention includes a three-session, six-module program for AGYW that increases knowledge, skills, and self-efficacy to engage along the HIV prevention and care continuum, and a two-session, four-module program for caregivers to increase social support.
In addition, the SHIELD intervention includes youth clubs to foster peer support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV Testing
Time Frame: 6 months
|
Proportion of cohort not living with HIV that self-reported being tested for HIV in the past 6 months.
|
6 months
|
|
HIV-/u Proportion Tested for HIV in the Past 6 Months
Time Frame: 12 months
|
Proportion of cohort not living with HIV that self reported being tested for HIV in past 6 months.
|
12 months
|
|
Retention in Care
Time Frame: 12 months
|
HIV+ cohort proportion with at least one visit during the 12-months follow-up.
Data were not collected from any participant due to COVID 19 pandemic and associated restrictions, and will not be collected in the future.
|
12 months
|
|
HIV+ Proportion With Undetectable Viral Load at 12 Months
Time Frame: At 12 months since study initiation
|
Proportion of cohort living with HIV who had an undetectable (less than 40 copies/mL) viral load
|
At 12 months since study initiation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV Risk Behavior - Delay in First Intercourse
Time Frame: Baseline
|
Self-reported age of first intercourse among HIV-/u cohort.
|
Baseline
|
|
HIV Risk Behavior - Delay in First Intercourse
Time Frame: 6 months
|
Self reported age of first intercourse among HIV-/u cohort.
|
6 months
|
|
HIV Risk Behavior - Delay in First Intercourse
Time Frame: 12 months
|
HIV-/u self reported age of first intercourse.
|
12 months
|
|
HIV Risk Behavior - Reduction in Sexual Partners
Time Frame: Baseline
|
Self reported number of casual partners in the last 3 months among HIV-/u cohort.
|
Baseline
|
|
HIV Risk Behavior - Reduction in Sexual Partners
Time Frame: 6 months
|
Self-reported number of casual partners in last 3 months among HIV-/u cohort.
|
6 months
|
|
HIV Risk Behavior - Reduction in Sexual Partners
Time Frame: 12 months
|
Self-reported number of casual partners in last 3 months among HIV-/u cohort.
|
12 months
|
|
HIV Risk Behavior - Increases in Condom Use
Time Frame: Baseline
|
HIV-/u AGYW who reported always using condoms with casual partners in past 3 months.
|
Baseline
|
|
HIV Risk Behavior - Increases in Condom Use
Time Frame: 6 months
|
HIV-/u AGYW who reported always using condoms with casual partners in past 3 months.
|
6 months
|
|
HIV Risk Behavior - Increases in Condom Use
Time Frame: 12 months
|
HIV-/u AGYW who reported always using condoms with casual partners in past 3 months.
|
12 months
|
|
HIV Early Detection
Time Frame: 12 months
|
HIV-/u proportion with HIV identified through voluntary testing.
|
12 months
|
|
Linkages to HIV Care - Enrollment at HIV Clinic
Time Frame: 6 months
|
Proportion enrolled at an HIV clinic in ≤ 30 days
|
6 months
|
|
Linkages to HIV Care - Enrollment at HIV Clinic
Time Frame: 12 months
|
Proportion enrolled at an HIV clinic in ≤ 30 days
|
12 months
|
|
Linkages to HIV Care - ART Initiation
Time Frame: 6 months
|
Proportion with ART initiated in ≤ 90 days
|
6 months
|
|
Linkages to HIV Care - ART Initiation
Time Frame: 12 months
|
Proportion with ART initiated in ≤ 90 days
|
12 months
|
|
Adherence to ART
Time Frame: 6 months
|
AGYW living with HIV who self-reported "Excellent" medication adherence.
|
6 months
|
|
Adherence to ART
Time Frame: 12 months
|
AGYW living with HIV who self-reported "Excellent" medication adherence.
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sujha Subramanian, PhD, Implenomics
Publications and helpful links
General Publications
- Subramanian S, Edwards P, Roberts ST, Musheke M, Mbizvo M. Integrated Care Delivery for HIV Prevention and Treatment in Adolescent Girls and Young Women in Zambia: Protocol for a Cluster-Randomized Controlled Trial. JMIR Res Protoc. 2019 Oct 3;8(10):e15314. doi: 10.2196/15314.
- Blackburn NA, Scanlon SL, Beizer J, Chelwa N, Nyblade L, Roberts ST, Phiri L, Mulenga D, Mbizvo M, Subramanian S. The Implementation and Costs To Deliver a youth-friendly multi-component Program Addressing Stigma, HIV, and Linkage To Care for Adolescent Girls and Young Women in Lusaka, Zambia. AIDS Behav. 2025 Jul;29(7):2179-2188. doi: 10.1007/s10461-025-04682-2. Epub 2025 Mar 20.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1UG3HD096908-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Risk Behavior | HIV Counseling and TestingUnited States
Clinical Trials on Integrated wellness care (IWC) clinics
-
Albert Einstein College of MedicineNational Institute of Mental Health (NIMH); HIV Center for Clinical & Behavioral...CompletedHuman Immunodeficiency Virus TransmissionUnited States
-
University Hospitals, LeicesterWarwick Medical SchoolCompleted
-
University of Kansas Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingChild Language | Language Delay | Developmental MilestonesUnited States
-
Association de Recherche Experimentale et Clinique...Unknown
-
East Carolina UniversityThe Kate B. Reynolds Charitable TrustCompleted
-
University of SouthamptonUniversity Hospital Southampton NHS Foundation Trust; University of Birmingham and other collaboratorsCompleted
-
Zealand University HospitalSteno Diabetes Center SjaellandCompletedDiabetes Mellitus | Diabetes | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot UlcerDenmark
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
Scott & White Health PlanCompletedChronic IllnessUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Delusional Disorder | Psychotic Disorder NOS | Severe Major Depression With Psychotic FeaturesGermany